GCG and Insulin resistance: Furthermore, as antagonism of the glucagon receptor has been shown to improve islet function in mice with insulin resistance induced by a HFD (48), GSK706A could suggestively be combined with an inhibitor of glucagon action to achieve more potent glucose-lowering effects.